ASGCT Late Breakers: Pfizer’s Duchenne Results Underwhelm As Next-Gen Approaches Emerge

Sarepta Set For Landmark Approval

LA Convention Center
An aerlal view of the L.A. Convenstion Center, the venue for this year's ASGCT annual congress. • Source: Shutterstock

More from Clinical Trials

More from R&D